Altimmune Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.6% | -28.2% | -99.4% | +92,891.9% | -38.8% | -99.8% | +48,849.8% | +9.0% | -1.7% | +14.2% | -45.0% | -60.4% | -10.6% | +284.3% | -67.4% | +307.1% | -21.3% | -63.8% | -83.7% | +15.3% | +1,974.1% | -99.0% | -75.0% | -75.0% | -5,600.0% | – | -71.4% | +5,933.3% | -89.8% | -86.5% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +420.0% | -100.0% | – | – | |
| – | -1.0% | +17.2% | +88.6% | +12.4% | -6.7% | +4.4% | -14.4% | -3.9% | -35.2% | +5.0% | -8.5% | +196.4% | -75.1% | +150.2% | +205.2% | +2.7% | -11.9% | -26.7% | +20.7% | +120.1% | -27.9% | -19.8% | -5.3% | +26.7% | -5.3% | -101.9% | – | +38.7% | -89.7% | -94.3% | -43.0% | -39.3% | -10.8% | – | – | +49,766.7% | -99.8% | -11.5% | +0.0% | – | |
| – | – | – | – | – | – | -349.2% | – | – | – | -110.1% | – | – | – | – | – | +307.1% | -532.0% | – | – | – | – | – | – | -253,350.0% | – | – | -63,181.0% | – | – | -375.7% | – | +0.0% | +0.0% | +0.0% | +0.0% | -299,200.0% | – | -188.5% | – | – | |
| – | +15.4% | -49.1% | +624.0% | +12.4% | -24.5% | +28.9% | -14.4% | -3.9% | -35.2% | +5.0% | -8.5% | +196.4% | -55.6% | +85.6% | +130.9% | +2.7% | -47.5% | +32.7% | +11.7% | +120.1% | -30.9% | -25.2% | +5.9% | +26.7% | -5.3% | -10.1% | -23.2% | +38.7% | -8.0% | +27.1% | -1.5% | -6.4% | -0.1% | -20.0% | +8.9% | -13.2% | +23.1% | -12.2% | +15.4% | – | |
| – | +39.2% | -37.6% | -44.4% | +69.3% | -47.6% | +53.6% | +19.9% | -33.1% | +23.2% | -14.6% | +8.0% | -2.0% | -7.9% | +15.7% | +9.2% | +65.8% | -2.6% | -7.1% | -4.2% | +13.6% | -9.1% | +17.2% | -0.4% | +1.9% | -15.3% | +19.1% | +5.1% | -5.2% | -4.0% | +22.6% | +5.3% | -11.2% | +2.4% | +17.7% | -5.0% | +3.7% | +78.0% | -23.4% | -5.9% | – | |
| – | +33.1% | -39.9% | +0.7% | +122.7% | -32.3% | -9.0% | +42.6% | -14.8% | -18.0% | -3.7% | -2.0% | +110.9% | -75.1% | +50.4% | +368.9% | +11.1% | -109.1% | – | +149.5% | -64.6% | +49.6% | -57.4% | +670.8% | -78.0% | -15.3% | +472.4% | -78.1% | -5.2% | +645.7% | -20.7% | +0.2% | -7.4% | +0.4% | -12.3% | +5.1% | -74.2% | +389.8% | -16.2% | +8.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,787,308,573.5% | -100.0% | +60.3% | -97.6% | -13.1% | -57.3% | +120.8% | +8,590.6% | -23.7% | -99.4% | +1.1% | +1.1% | +297,022.2% | -99.9% | +75.5% | -31.2% | -14.2% | +514.4% | +83.3% | +50.0% | +85.2% | +1.5% | +4.8% | -1.5% | +185.9% | -98.9% | +0.0% | +1,350.0% | -93.1% | -50.0% | +0.0% | +500.0% | -83.3% | +0.0% | +26,300.0% | +87.5% | +77.0% | +21.9% | +2.7% | – | |
| – | -18.6% | -103.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +71,954.6% | -109.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -119.4% | – | -624.2% | – | – | – | +118.9% | -827.9% | – | – | -11.0% | +234.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -28.8% | -102.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.